~~<i id='08AFB5AF63'><strike id='08AFB5AF63'><tt id='08AFB5AF63'><pre id='08AFB5AF63'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

comprehensive

author：explore 2025-08-23 08:54:47 - browse：4

Pharmacy shelves — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter. GEORGE FREY/AFP via Getty Images

WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter — its highest-ever spend by far, according to federal filings.

The Council for Citizens Against Government Waste spent $1.1 million on lobbying last quarter, and only employed a single lobbyist. That’s 22 times the $50,000 it spent in the same quarter last year. Its prior spending record was $700,000, from the start of 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Is there really a nursing shortage in the U.S.?

focus

hotspot

focus

leisure time

entertainment

hotspot

AdobeOnAug.29,Medicarereleaseditshighlyanticipatedlistof10therapiesforwhichitplanstoestablishapriceb

WSS

FDA proposes changes to key medical devices approval pathway

How medical schools plan to diversify without affirmative action

FDA approves updated Covid vaccines

Acelyrin, a rare IPO success, stumbles in its first big test

Long Covid needs a new name — and a new frame

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

knowledge

comprehensive

focus

Medical leaders decry Supreme Court decision on affirmative action

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Continuity nursing helped my family in our darkest PICU moments

How AI can help patients find reliable information about doctors

Guidelines to prevent youth baseball injuries need more muscle

Food makers to regulators: Ultra

The cancer drug shortage isn’t new — and neither are the solutions

Generate Biomedicines machine learning biotech raises $273M

Heart attack and stroke risk calculators need revising

Hospitals consider fixing cancer drug shortages on their own

hotspot

New weight loss drugs vying to be the next Wegovy or Mounjaro

What to make of Biden’s latest efforts on cancer research

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Pig kidney works a record two months in donated body

STAT Summit: Ending the crisis of Black deaths in the U.S.

Smaller biotechs seek to piggyback on weight loss drug boom

focus

leisure time

entertainment

hotspot